MedPath

Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis

Not Applicable
Completed
Conditions
Nasal Mucosal Disorder
Hypersensitivity Pneumonitis
Interventions
Procedure: nasal endoscopy
Registration Number
NCT05723796
Lead Sponsor
Cairo University
Brief Summary

Background:Hypersensitivity pneumonitis (HP) is an interstitial lung disease that develops after inhalation of organic or inorganic antigens in susceptible individuals. The nasal mucosa is constantly exposed to these antigens that can irritate the respiratory mucosa.

Objectives: to assess the burden of sinonasal symptoms in HP patients and to evaluate the nasal histopathology in those patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • all patients with clinical and radiological features of HP
Exclusion Criteria
  • respiratory failure
  • patients on anticoagulants

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
chronic HP patientsnasal endoscopy-
Primary Outcome Measures
NameTimeMethod
percentage of patients with HP developed nasal mucosa granuloma and lymphocytic infiltrations as detected by nasal endoscopy6 months

nasal endoscopy and nasal mucosa biopsy was done for all patients to measure the % of patients with nasal granuloma and lymphocytic infiltrations

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr alainy school of medicine

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath